[HTML][HTML] Reviewing primary Sjögren's syndrome: beyond the dryness-From pathophysiology to diagnosis and treatment
T Both, VASH Dalm, PM van Hagen… - International journal of …, 2017 - ncbi.nlm.nih.gov
Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease, characterized by
lymphocytic infiltration of the secretory glands. This process leads to sicca syndrome, which is …
lymphocytic infiltration of the secretory glands. This process leads to sicca syndrome, which is …
[HTML][HTML] Determinants of serum immunoglobulin levels: a systematic review and meta-analysis
…, RP Peeters, PM van Hagen, VASH Dalm… - Frontiers in …, 2021 - frontiersin.org
Background An up-to-date overview of determinants of serum immunoglobulins in adults is
pivotal for clinical practice and research, but currently lacking. We therefore performed a …
pivotal for clinical practice and research, but currently lacking. We therefore performed a …
Everything you need to know about distal renal tubular acidosis in autoimmune disease
…, EJ Hoorn, PM van Hagen, VASH Dalm… - Rheumatology …, 2014 - Springer
Renal acid–base homeostasis is a complex process, effectuated by bicarbonate reabsorption
and acid secretion. Impairment of urinary acidification is called renal tubular acidosis (RTA)…
and acid secretion. Impairment of urinary acidification is called renal tubular acidosis (RTA)…
Immunogenicity and reactogenicity of vaccine boosters after Ad26. COV2. S priming
…, MPG Koopmans, VASH Dalm… - … England Journal of …, 2022 - Mass Medical Soc
Background The Ad26.COV2.S vaccine, which was approved as a single-shot immunization
regimen, has been shown to be effective against severe coronavirus disease 2019. …
regimen, has been shown to be effective against severe coronavirus disease 2019. …
[HTML][HTML] Coronavirus disease 2019 in patients with inborn errors of immunity: an international study
Background There is uncertainty about the impact of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection in individuals with rare inborn errors of immunity (IEI), a …
coronavirus 2 (SARS-CoV-2) infection in individuals with rare inborn errors of immunity (IEI), a …
Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib
VK Rao, S Webster, VASH Dalm… - Blood, The Journal …, 2017 - ashpublications.org
Pathogenic gain-of-function variants in the genes encoding phosphoinositide 3-kinase δ (PI3Kδ)
lead to accumulation of transitional B cells and senescent T cells, lymphadenopathy, …
lead to accumulation of transitional B cells and senescent T cells, lymphadenopathy, …
Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells
VASH Dalm, PM Van Hagen… - American Journal …, 2003 - journals.physiology.org
Increasing evidence suggests that neuropeptides play a role in the regulatory mechanisms
between the neuroendocrine and immune systems. A differential expression of the five …
between the neuroendocrine and immune systems. A differential expression of the five …
Clinical characteristics and outcomes of immunocompromised patients with coronavirus disease 2019 caused by the omicron variant: a prospective, observational …
SRK Malahe, RAS Hoek, VASH Dalm… - Clinical Infectious …, 2023 - academic.oup.com
Background Illness after infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron variant is less severe compared with previous variants. Data on the …
Omicron variant is less severe compared with previous variants. Data on the …
MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome
…, PL van Daele, VASH Dalm… - Annals of the …, 2014 - ard.bmj.com
Objective To establish an easy and practical assay for identifying systemic interferon (IFN)
type I bioactivity in patients with primary Sjögren's syndrome (pSS). The IFN type I signature is …
type I bioactivity in patients with primary Sjögren's syndrome (pSS). The IFN type I signature is …
Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome
…, F Cox, E Crickx, B Dalgic, VASH Dalm… - Journal of Allergy and …, 2023 - Elsevier
Background In 2014, germline signal transducer and activator of transcription (STAT) 3 gain-of-function
(GOF) mutations were first described to cause a novel multisystem disease of …
(GOF) mutations were first described to cause a novel multisystem disease of …